BIOCEPT, INC. Net Income (Loss) Available to Common Stockholders, Basic
BIOCEPT, INC. reported Net Income (Loss) Available to Common Stockholders, Basic of -$3.63 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2023-08-14
- BIOCEPT, INC. net income (loss) available to common stockholders, basic for the quarter ending 2023-06-30 was -$3.63M.
- BIOCEPT, INC. net income (loss) available to common stockholders, basic for the quarter ending 2023-03-31 was -$7.14M.
- BIOCEPT, INC. net income (loss) available to common stockholders, basic for the quarter ending 2022-12-31 was -$9.71M.
- BIOCEPT, INC. net income (loss) available to common stockholders, basic for the quarter ending 2022-09-30 was -$10.13M.
- BIOCEPT, INC. net income (loss) available to common stockholders, basic for fiscal 2022 was -$32.09M.
- BIOCEPT, INC. net income (loss) available to common stockholders, basic for fiscal 2021 was -$2.82M.
- BIOCEPT, INC. net income (loss) available to common stockholders, basic for fiscal 2020 was -$17.81M.
- BIOCEPT, INC. net income (loss) available to common stockholders, basic for fiscal 2019 was -$25.26M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 12 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | -$3.63M 10-Q · filed 2023-08-14 | -$10.78M 10-Q · filed 2023-08-14 | -$20.48M derived: sum of 3 quarters · filed 2023-08-14 | -$30.61M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2023-03-31 | -$7.14M 10-Q · filed 2023-05-10 | -$16.85M derived: sum of 2 quarters · filed 2023-05-10 | -$26.98M derived: sum of 3 quarters · filed 2023-05-10 | -$37.02M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-12-31 | -$9.71M derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-04-17 | -$19.83M derived: sum of 2 quarters · filed 2023-04-17 | -$29.88M derived: sum of 3 quarters · filed 2023-08-14 | -$32.09M 10-K · filed 2023-04-17 | ||||
| 2022-09-30 | -$10.13M 10-Q/A · filed 2023-04-17 | -$5.54M 10-Q · filed 2022-11-21 | -$20.17M derived: sum of 2 quarters · filed 2023-08-14 | -$22.38M 10-Q/A · filed 2023-04-17 | -$13.56M 10-Q · filed 2022-11-21 | -$25.35M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-06-30 | -$10.04M 10-Q · filed 2023-08-14 | -$5.25M 10-Q · filed 2022-11-10 | -$12.26M 10-Q · filed 2023-08-14 | -$8.02M 10-Q · filed 2022-11-10 | -$15.22M derived: sum of 3 quarters · filed 2023-08-14 | -$15.85M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | -$2.21M 10-Q · filed 2023-05-10 | -$2.77M 10-Q · filed 2022-05-23 | -$5.18M derived: sum of 2 quarters · filed 2023-05-10 | -$5.81M derived: sum of 3 quarters · filed 2023-05-10 | -$7.63M derived: sum of 4 quarters · filed 2023-05-10 | |||
| 2021-12-31 | -$2.97M derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-04-17 | -$3.60M derived: sum of 2 quarters · filed 2023-04-17 | -$5.42M derived: sum of 3 quarters · filed 2023-04-17 | -$2.82M 10-K · filed 2023-04-17 | ||||
| 2021-09-30 | -$625.00K 10-Q/A · filed 2023-04-17 | $427.05K 10-Q · filed 2021-11-15 | -$2.45M derived: sum of 2 quarters · filed 2023-04-17 | $147.00K 10-Q/A · filed 2023-04-17 | $1.20M 10-Q · filed 2021-11-15 | $19.69B derived: sum of 4 quarters · filed 2023-04-17 | ||
| 2021-06-30 | -$1.83M 10-Q · filed 2022-11-10 | -$1.83M 10-Q · filed 2021-08-16 | $772.00K 10-Q · filed 2022-11-10 | $771.81K 10-Q · filed 2021-08-16 | $19.69B derived: sum of 3 quarters · filed 2022-11-10 | $14.82B derived: sum of 4 quarters · filed 2022-11-10 | ||
| 2021-03-31 | $2.60M 10-Q · filed 2022-05-23 | $2.60M 10-Q · filed 2021-05-12 | $19.70B derived: sum of 2 quarters · filed 2022-05-23 | $14.82B derived: sum of 3 quarters · filed 2022-05-23 | $14.81B derived: sum of 4 quarters · filed 2022-05-23 | |||
| 2020-12-31 | $19.69B derived: 10-K 12 month − 10-K 9 month · filed 2022-04-05 | $14.82B derived: sum of 2 quarters · filed 2022-04-05 | $14.81B derived: sum of 3 quarters · filed 2022-04-05 | -$17.81M 10-K · filed 2022-04-05 | -$17.81M 10-K · filed 2021-03-31 | |||
| 2020-09-30 | -$4.88B 10-K · filed 2022-04-05 | -$4.88M 10-Q · filed 2020-11-16 | -$4.88B derived: sum of 2 quarters · filed 2022-04-05 | -$19.71B 10-K · filed 2022-04-05 | -$19.71M 10-Q · filed 2020-11-16 | -$4.90B derived: sum of 4 quarters · filed 2022-04-05 | ||
| 2020-06-30 | -$6.49M 10-Q · filed 2021-08-16 | -$14.83M 10-Q · filed 2021-08-16 | -$20.57M derived: sum of 3 quarters · filed 2021-08-16 | -$26.26M derived: sum of 4 quarters · filed 2021-08-16 | ||||
| 2020-03-31 | -$8.34M 10-Q · filed 2021-05-12 | -$14.08M derived: sum of 2 quarters · filed 2021-05-12 | -$19.77M derived: sum of 3 quarters · filed 2021-05-12 | -$27.59M derived: sum of 4 quarters · filed 2021-05-12 | ||||
| 2019-12-31 | -$5.74M 10-K · filed 2020-03-27 | -$11.43M derived: sum of 2 quarters · filed 2020-11-16 | -$19.24M derived: sum of 3 quarters · filed 2020-11-16 | -$25.26M 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | -$5.69M 10-Q · filed 2020-11-16 | -$13.51M derived: sum of 2 quarters · filed 2020-11-16 | -$19.52M 10-Q · filed 2020-11-16 | -$25.54M derived: sum of 4 quarters · filed 2020-11-16 | ||||
| 2019-06-30 | -$7.82M 10-Q · filed 2020-08-13 | -$13.83M 10-Q · filed 2020-08-13 | -$19.85M derived: sum of 3 quarters · filed 2020-08-13 | -$26.53M derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | -$6.02M 10-Q · filed 2020-05-14 | -$12.03M derived: sum of 2 quarters · filed 2020-05-14 | -$18.71M derived: sum of 3 quarters · filed 2020-05-14 | -$24.87M derived: sum of 4 quarters · filed 2020-05-14 | ||||
| 2018-12-31 | -$6.01M 10-K · filed 2020-03-27 | -$12.70M derived: sum of 2 quarters · filed 2020-03-27 | -$18.85M derived: sum of 3 quarters · filed 2020-03-27 | -$25.21M 10-K · filed 2020-03-27 | ||||
| 2018-09-30 | -$6.68M 10-K · filed 2020-03-27 | -$12.84M derived: sum of 2 quarters · filed 2020-03-27 | -$19.19M 10-Q · filed 2019-11-13 | -$24.86M derived: sum of 4 quarters · filed 2020-03-27 | ||||
| 2018-06-30 | -$6.15M 10-K · filed 2020-03-27 | -$12.51M 10-Q · filed 2019-08-14 | -$18.18M derived: sum of 3 quarters · filed 2020-03-27 | -$24.00M derived: sum of 4 quarters · filed 2020-03-27 | ||||
| 2018-03-31 | -$6.36M 10-K · filed 2020-03-27 | -$12.02M derived: sum of 2 quarters · filed 2020-03-27 | -$17.84M derived: sum of 3 quarters · filed 2020-03-27 | |||||
| 2017-12-31 | -$5.67M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | -$11.49M derived: sum of 2 quarters · filed 2019-03-29 | -$21.61M 10-K · filed 2019-03-29 | |||||
| 2017-09-30 | -$5.82M 10-Q · filed 2018-11-14 | -$15.95M 10-Q · filed 2018-11-14 |